Last week, the maker of Durex announced it was buying a baby-formula company for $17 billion and th…

If the deal makes its way past shareholders and regulators, and if it doesn't run into too much tro…

The COVID-19 vaccine unlocked the potential of mRNA technology and new ways of approaching problems…

Here are the five companies that saw the biggest combined stock purchases from insiders during the …

In a world where the corporate landscape has traditionally been male-dominated, Indian women have b…

Biopharmaceuticals specialist Abbvie and drugmaker Allergan expect the merger to create a leading p…

"The proposed acquisition of Array strengthens our innovative biopharmaceutical business, is expect…

"We now have six near-term launch opportunities, and I stress the term 'near-term' - a number of th…

JPMorgan confirmed to Business Insider that Anu Aiyengar is now the sole head of M&A for North …

These details are revealed in a new Spark financial filing about the transaction. Though the other …

The biopharmaceutical company has typically bought earlier-stage companies, translating to relative…

1. The top story on Monday was a massive merger in the pipeline space, with Kinder Morgan consolida…

Pharma giants are pouring billions into the promising space. In the last week alone, Swiss drug gia…

As in its previous proposal, Pfizer is considering a possible transaction in which AstraZeneca shar…